Parkland Group
VC Fund
Shenzhen, China
Parkland Group is an investment group that specializes in real estate development. In addition, they also have business interests spanning the health industry, commercial operations, property management, and PE investment. With forward-thinking strategic planning, a sound management system, and market-leading capabilities that increasinglystrengthen their brand influence, they have always been committed to creating a high quality of life. The group engages in estate development, commercial operations, PE investments, and property management.It is headquartered in Shenzhen, China.
- Total investments:
- 10
- Last investment:
- Lead investor:
- 10%
Last updated:
For AI agents: llms.txt
Industries Parkland Group invests in
Stages Parkland Group invests in
Countries Parkland Group invests in
Investment Focus
Industry
- Medical 5 (50%)
- Health Care 3 (30%)
- Manufacturing 3 (30%)
- Biotechnology 2 (20%)
- Artificial Intelligence 2 (20%)
Stage
- Seed 3 (30%)
- Series A 3 (30%)
- Angel 1 (10%)
- Series B 1 (10%)
- Funding Round 1 (10%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
Kunteng Tech develops auxiliary drives for electric and hybrid passenger cars and delivers medium- and low-voltage high-power and high-voltage high-power. | Seed / Jul 11, 2024 | |
|
|
Linli New Energy is a smart hardware company that develops and manufactures precursors of lithium iron phosphate cathode materials. It was founded in 2016 in Wuhan, Hubei, China. | Nov 04, 2021 | |
|
|
Linli New Energy is a smart hardware company that develops and manufactures precursors of lithium iron phosphate cathode materials. It was founded in 2016 in Wuhan, Hubei, China. | Venture - Series Unknown / Nov 04, 2021 | |
|
|
Cloudpick Technology is a high-tech enterprise specializing in the development of computer vision and artificial intelligence applications. The company is committed to leading the technological breakthrough of the core knowledge of artificial intelligence and building an overall application solution for artificial intelligence and big data analysisin multiple industries. | Series A / Jul 20, 2020 | |
|
|
Jiabao Kangle is a professional brand chain of pediatrics, children with foreign advanced technology and medical and health management philosophy, the combination of Internet and artificial intelligence technology, to build China's most authoritative, most professional children's medical and health management platform | Series A / Aug 29, 2019 | |
|
|
Abmart specializes in antibody customization and antibody-related services. | $2.8M / Series B / Jun 12, 2018 | |
|
|
Biological product company based in Jiangsu. | Seed / Apr 25, 2018 | |
|
|
Vedeng provides a platform connecting upstream manufacturers with medical equipment dealers and private clinics. At present, the firm has established a comprehensive digital infrastructure including front-end marketing, procurement systems, logistics, after-sales service and back-end commodity databases, covering 970,000 grassroots and privatemedical customers. | $662K / Seed / Jul 01, 2015 | |
|
|
Genetron Health is a world-leading expert in precision medicine.They are committed to developing health management products that cover all elements of full-cycle cancer clinical treatment (including risk assessment, early screening, molecular pathology diagnosis, medication guidance and prognosis monitoring) and effectively applying genomic data toassist medical experts and research scientists. Additionally, they provide cancer patients and high-risk and healthy individuals with reliable molecular clinical services and professional cancer genetic risk assessment.In just three years, Genetron Health has built global genomics sequencing and bioinformatics platforms, established two research and development centers in both North Carolina, U.S., and Beijing, China, and set up clinical laboratories in Beijing, Shanghai, Hangzhou and Chongqing of over 10,000 square meters.In the future, Genetron Health will spread its sales network throughout China with professional marketing, product management, medical experts and scientific research teams, and will provide service for Chinese and global cancer patients with its strong foundation in cancer genomics and efficient clinical translation. | $1.5M / Series A / Jul 01, 2015 | |
|
|
Regenovo provides 3D printing technology solutions in the biomedical field. | $425K / Angel / Jun 25, 2015 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Parkland Group invest in?
Parkland Group invests primarily in Medical, Health Care and Manufacturing startups, most often at Seed and Series A stage. Most of the 10 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Parkland Group last invest?
The most recent investment recorded for Parkland Group closed in Jul 2024. Shizune tracks 10 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!